LIS Links
First and Largest Academic Social Network of LIS Professionals in India
LIS Links Becoming More Social
Birthdays
Birthdays Today
Latest Activity
National Level Workshop on “Smart Publishing in the Digital Age: Strategies for Journal Publishing and Academic Profile Management” (Hybrid Mode) on 15th November 2025 at Hybrid Mode
November 15, 2025 from 8am to 5pm
Request to Participate in Research Study on AI Adoption in LIS at India
October 19, 2025 at 6pm to November 30, 2025 at 7pm
ICSSSM 2025: First International Conference on Smart Systems and Social Management at The Assam Royal Global University, Guwahati
November 6, 2025 to November 8, 2025
22nd MANLIBNET Convention and International Conference on Marching Beyond the Libraries: Talent, Technology, and Transformation (ICMBL) at KIIT Deemed to be University, Bhubaneswar, Odisha
December 18, 2025 at 9:30am to December 20, 2025 at 7:30pm
HARI DATT PANDEY's Forum
Current Scenario of IPR with Reference to Copyright on Information Services in India: A Study
1 Reply
Respected Sir /Madam,I am a student from Indira Gandhi National Open University doing my MLIS (Master’s Degree in Library and Information Science), as per the project requirement we are conducting a…Continue
Started this Forum. Last reply by Siddhartha Shankar Ray Feb 20, 2013.
HARI DATT PANDEY's Page
Latest Activity
Profile Information
- Type of Working Institute
- IGNOU NEW DELHI IN JUNE 2011
- Name of the Indian State of Permanent Residential Address
- Punjab
© 2025 Created by Dr. Badan Barman.
Powered by
Comment Wall (3 comments)
You need to be a member of LIS Links to add comments!
Join LIS Links
BROCHURE.pdfNational Conference on
“Role of ICT in Library Management”
jointly organised by
Library Professionals Association (LPA), New Delhi &
Lyallpur Khalsa College of Engineering, Jalandhar (Punjab)
on
APRIL 26, 2014 (Saturday)
Venue: Lyallpur Khalsa College of Engineering, Cantt. Road, Jalandhar (Punjab)
Dear Sri Pande:
As I understand that with the recent patent battle regarding certain anti-carcinogenic drugs, the Swiss Multinational Novartis has opted to shrink its R&D investment in India. Do you feel that it will enhance your R&D activities especially in the fields of Vaccine Development & monoclonal antibodies? I am interested to know. However, in case it, in any way,create any possibility to affects your policy secrecy, please do not write anything.
Best Wishes,
Siddhartha S. Ray, Calcutta
Dear Sir / Madam,
I am not for a students of LPU. i am presently doing MLISc. from IGNOU new Delhi.
Kindly currect the my profile.